Escalon Medical Corp.

Escalon Medical Corp. reported modest profitability for Q2 2026 (period ending December 31, 2025) with net revenues of $3.6 million and net income applicable to common stockholders of $44,000. The company generated operating income of $99,000 from operations, though net cash used in operating activities was -$432,000. Key financial drivers included gross profit of $1.6 million (calculated from $3.6M revenue minus $2.0M cost of goods sold) and effective cost management with total costs and expenses of $3.5 million. The balance sheet shows total assets of $5.0 million with shareholders' equity of $1.8 million, though cash decreased by $465,000 during the quarter to $337,000. No prior period comparisons are provided in the data, limiting trend analysis.

Key Takeaways